ADN-237: A Breakthrough in Neuroprotection for Alzheimer and Parkinson
ADN-237 is a neuroprotective drug candidate, designed to combat neurological diseases and cognitive decline. Due to its unique properties, ADN-237 has shown early promise in clinical trials aimed at evaluating […]